207 related articles for article (PubMed ID: 8731108)
1. Growth promoting effects of growth hormone and IGF-I are additive in experimental uremia.
Kovács GT; Oh J; Kovács J; Tönshoff B; Hunziker EB; Zapf J; Mehls O
Kidney Int; 1996 May; 49(5):1413-21. PubMed ID: 8731108
[TBL] [Abstract][Full Text] [Related]
2. Differential long-term effects of insulin-like growth factor-I (IGF-I) growth hormone (GH), and IGF-I plus GH on body growth and IGF binding proteins in hypophysectomized rats.
Fielder PJ; Mortensen DL; Mallet P; Carlsson B; Baxter RC; Clark RG
Endocrinology; 1996 May; 137(5):1913-20. PubMed ID: 8612531
[TBL] [Abstract][Full Text] [Related]
3. Hypoglycemic effects of insulin-like growth factor-1 in experimental uremia: can concomitant growth hormone administration prevent this effect?
Kovacs GT; Worgall S; Schwalbach P; Steichele T; Mehls O; Rosivall L
Horm Res; 1999; 51(4):193-200. PubMed ID: 10474022
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human insulin-like growth factor (IGF)-binding protein-1 inhibits somatic growth stimulated by IGF-I and growth hormone in hypophysectomized rats.
Cox GN; McDermott MJ; Merkel E; Stroh CA; Ko SC; Squires CH; Gleason TM; Russell D
Endocrinology; 1994 Nov; 135(5):1913-20. PubMed ID: 7525258
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone prevents steroid-induced growth depression in health and uremia.
Kovàcs G; Fine RN; Worgall S; Schaefer F; Hunziker EB; Skottner-Lindun A; Mehls O
Kidney Int; 1991 Dec; 40(6):1032-40. PubMed ID: 1762304
[TBL] [Abstract][Full Text] [Related]
6. Combined treatment with GH and IGF-I: additive effect on cortical bone mass but not on linear bone growth in female rats.
Sundström K; Cedervall T; Ohlsson C; Camacho-Hübner C; Sävendahl L
Endocrinology; 2014 Dec; 155(12):4798-807. PubMed ID: 25243853
[TBL] [Abstract][Full Text] [Related]
7. Short-term growth hormone or IGF-I administration improves the IGF-IGFBP system in arthritic rats.
López-Menduiña M; Martín AI; Castillero E; Villanúa MA; López-Calderón A
Growth Horm IGF Res; 2012 Feb; 22(1):22-9. PubMed ID: 22244673
[TBL] [Abstract][Full Text] [Related]
8. Improvement of growth and food utilization by human recombinant growth hormone in uremia.
Mehls O; Ritz E; Hunziker EB; Eggli P; Heinrich U; Zapf J
Kidney Int; 1988 Jan; 33(1):45-52. PubMed ID: 3352160
[TBL] [Abstract][Full Text] [Related]
9. The obese growth hormone (GH)-deficient dwarf rat: body fat responses to patterned delivery of GH and insulin-like growth factor-I.
Clark RG; Mortensen DL; Carlsson LM; Carlsson B; Carmignac D; Robinson IC
Endocrinology; 1996 May; 137(5):1904-12. PubMed ID: 8612530
[TBL] [Abstract][Full Text] [Related]
10. Effects of rhGH and rhIGF-1 on renal growth and morphology.
Mehls O; Irzynjec T; Ritz E; Eden S; Kovàcs G; Klaus G; Floege J; Mall G
Kidney Int; 1993 Dec; 44(6):1251-8. PubMed ID: 7905540
[TBL] [Abstract][Full Text] [Related]
11. IGF-I and IGF-I-binding proteins in rats with adjuvant-induced arthritis given recombinant human growth hormone.
Ibañez De Cáceres I; Villanúa MA; Soto L; Martin AI; López-Calderón A
J Endocrinol; 2000 Jun; 165(3):537-44. PubMed ID: 10828837
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-I gene expression in the tibial epiphyseal growth plate of growth hormone-treated uremic rats.
Hanna JD; Santos F; Foreman JW; Chan JC; Han VK
Kidney Int; 1995 May; 47(5):1374-82. PubMed ID: 7637267
[TBL] [Abstract][Full Text] [Related]
13. Effects of recombinant human insulin-like growth factor I (IGF-I) therapy on the growth hormone-IGF system of a patient with a partial IGF-I gene deletion.
Camacho-Hübner C; Woods KA; Miraki-Moud F; Hindmarsh PC; Clark AJ; Hansson Y; Johnston A; Baxter RC; Savage MO
J Clin Endocrinol Metab; 1999 May; 84(5):1611-6. PubMed ID: 10323388
[TBL] [Abstract][Full Text] [Related]
14. Short-term administration of a combination of recombinant growth hormone and insulin-like growth factor-I induces anabolism in maintenance hemodialysis.
Guebre-Egziabher F; Juillard L; Boirie Y; Laville M; Beaufrère B; Fouque D
J Clin Endocrinol Metab; 2009 Jul; 94(7):2299-305. PubMed ID: 19401377
[TBL] [Abstract][Full Text] [Related]
15. Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: comparison of two dosage levels and to GH-treated GH deficiency.
Guevara-Aguirre J; Rosenbloom AL; Vasconez O; Martinez V; Gargosky SE; Allen L; Rosenfeld RG
J Clin Endocrinol Metab; 1997 Feb; 82(2):629-33. PubMed ID: 9024266
[TBL] [Abstract][Full Text] [Related]
16. Leptin is suppressed during infusion of recombinant human insulin-like growth factor I (rhIGF I) in normal rats.
Böni-Schnetzler M; Hauri C; Zapf J
Diabetologia; 1999 Feb; 42(2):160-6. PubMed ID: 10064095
[TBL] [Abstract][Full Text] [Related]
17. Effects of recombinant human growth hormone and insulin-like growth factor-I, with or without 17 beta-estradiol, on bone and mineral homeostasis of aged ovariectomized rats.
Verhaeghe J; van Bree R; Van Herck E; Thomas H; Skottner A; Dequeker J; Mosekilde L; Einhorn TA; Bouillon R
J Bone Miner Res; 1996 Nov; 11(11):1723-35. PubMed ID: 8915780
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human insulin-like growth factor I, recombinant human growth hormone, and sex steroids: effects on markers of bone turnover in humans.
Mauras N; Doi SQ; Shapiro JR
J Clin Endocrinol Metab; 1996 Jun; 81(6):2222-6. PubMed ID: 8964855
[TBL] [Abstract][Full Text] [Related]
19. Combined recombinant human growth hormone and recombinant human insulin-like growth factor I: lack of synergy on whole body protein anabolism in normally fed subjects.
Mauras N
J Clin Endocrinol Metab; 1995 Sep; 80(9):2633-7. PubMed ID: 7673406
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor-I but not growth hormone attenuates dexamethasone-induced catabolism in parenterally fed rats.
Lo HC; Hinton PS; Yang H; Unterman TG; Ney DM
JPEN J Parenter Enteral Nutr; 1996; 20(3):171-7. PubMed ID: 8776688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
